Barrier dysfunction in IBS has been linked to the down-regulation of the tight junctions (TJ) scaffolding protein zonal occludins (ZO-1) [40] and also proteasome-mediated occludin degradation in the colonic mucosa of IBS patients [41]. The gene discussed is TJP1; the disease is irritable bowel syndrome.